The clinical and genetic profiles, management, and treatment outcomes of familial exudative vitreoretinopathy.

In 30 seconds

This meta-analysis of 99 studies involving 463 patients with familial exudative vitreoretinopathy highlights the importance of early screening, as nearly half of patients are asymptomatic at diagnosis. It identifies pathogenic mutations in 43% of cases and suggests that combination therapy reduces retinal detachment incidence in early-stage disease.

Key findings

• Nearly 50% of patients are asymptomatic at diagnosis, indicating a need for early screening.
• Pathogenic mutations were identified in 43% of cases, primarily in FZD4, LRP5, and NDP.
• Combination therapy reduced the incidence of retinal detachment in early-stage disease.
• Vitrectomy improved anatomical outcomes in advanced stages of the disease.

Why it matters

Understanding the clinical and genetic profiles of familial exudative vitreoretinopathy can guide clinicians in early detection and tailored management strategies, potentially improving patient outcomes.